Abstract:Several neurodevelopmental and neurodegenerative disorders affecting the central nervous system are potentially treatable via viral vector-mediated gene transfer. Adeno-associated viral (AAV) vectors have been used in clinical trials because of their desirable properties including a high degree of safety, efficacy, and stability. Major factors affecting tropism, expression level, and cell type specificity of AAV-mediated transgenes include encapsidation of different AAV serotypes, promoter selection, and the timing of vector administration. In this study, we evaluated the ability of single-stranded AAV2 vectors pseudotyped with viral capsids from serotype 9 (AAV2/9) to transduce the brain and target gene expression to specific cell types after intracerebroventricular injection into mice. Titer-matched AAV2/9 vectors encoding the enhanced green fluorescent protein (eGFP) reporter, driven by the cytomegalovirus (CMV) promoter, or the neuron-specific synapsin-1 promoter, were injected bilaterally into the lateral ventricles of C57/BL6 mice on postnatal day 5 (neonatal) or 21 (juvenile). Brain sections were analyzed 25 days after injection, using immunocytochemistry and confocal microscopy. eGFP immunohistochemistry after neonatal and juvenile administration of viral vectors revealed transduction throughout the brain including the striatum, hippocampus, cerebral cortex, and cerebellum, but with different patterns of cell-specific gene expression. eGFP expression was seen in astrocytes after treatment on postnatal day 5 with vectors carrying the CMV promoter, expanding the usefulness of AAVs for modeling and treating diseases involving glial cell pathology. In contrast, injection of AAV2/9-CMV-eGFP on postnatal day 21 resulted in preferential transduction of neurons. Administration of AAV2/9-eGFP with the synapsin-1 promoter on either postnatal day 5 or 21 resulted in widespread neuronal transduction. These results outline efficient methods and tools for gene delivery to the nervous system by direct, early postnatal administration of AAV vectors. Our findings highlight the importance of promoter selection and age of administration on the intensity, distribution, and cell type specificity of AAV transduction in the brain.

Gene delivery into primary cerebral cortical neurons by lentiviral vector.

Gene Transfer into Primary Cultures of Fetal Neural Stem Cells by a Recombinant Adenovirus Carrying the Gene for Green Fluorescent Protein

Comparison of Lentivirus and Adenovirus Vector Mediated Gene Transfer into Cultured Spiral Ganglion Cells

[Construction of Lentiviral Vectors Encoding GDNF and GDNF Expression in Human Neural Stem Cells].

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

Introduction of Green Fluorescent Protein (GFP) into Hippocampal Neurons Through Viral Infection.

Construction of bicistronic lentivirus vectors carrying hBDNF and GFP genes and transfection of neural stem cells

Enhanced green fluorescent protein gene-modified human bone marrow stromal cells induced by lentivirus

TRANSDUCTION OF i3NEURONS (Support Protocol 4) v1

Gene Transfer into the Nervous System using Recombinant Herpes Virus Vectors

Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice

A New Method of Gene Transfection into Cultured Hippocampal Neurons of Rats

Construction and transfection of the lentiviral vector containing glial cell line derived neurotrophic factor of rat

[Construction and Expression of Retroviral Vector Encoding Enhanced Green Fluorescent Protein]

Lentiviral Delivery of Proteins for Genome Engineering

In Intro Delivery of Gene Encoding Neurotrophic (GDNF) into Brain by Gene Transfer

Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System

Viral vectors for gene delivery to the central nervous system

[The Expression of Enhanced Green Fluorescent Protein Gene on Cultured Human Fetal Retinal Progenitor Cells].

An Improved Tet-on System for Gene Expression in Neurons Delivered by a Single Lentiviral Vector.

Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes